Elizabeth R. Plimack - Publications, H-index & Citations

Elizabeth R. Plimack

Fox Chase Cancer Center

79H指数

765论文数

4.8W被引数

收录论文 165

发表时间

Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma 肾细胞癌中免疫相关病理反应标准的可行性与表征

European Urology Oncology

IF9.3

2026-09-11

PREAI

Benjamin J. Croll; Hafiz A. Yahya; Jordan Fredette; Abigail Keller; Rainjade Chung; Shuanzeng Wei; Douglas Flieder; Fern Anari; Pooja Ghatalia; Elizabeth R. Plimack; Matthew R. Zibelman; Andres Correa; Alexander Kutikov; Randall Lee; Marc Smaldone; Robert Uzzo; Rosalia Viterbo; David Y.T. Chen; Daniel M. Geynisman

Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder Cancer 评估接受恩沃利单抗维多汀剂量降低治疗的转移性膀胱癌患者的治疗效果

Clinical Genitourinary Cancer

IF2.7

2026-06-01

PREAI

Rives, Hal; Fredette, Jordan; Anari, Fern; Ghatalia, Pooja; Geynisman, Daniel M.; Plimack, Elizabeth R.; Zibelman, Matthew

LONG-TERM FOLLOW-UP RESULTS OF AMVAC ARM OF ECOG-ACRIN EA8141: A PROSPECTIVE PHASE II TRIAL OF NEOADJUVANT SYSTEMIC CHEMOTHERAPY FOLLOWED BY EXTIRPATIVE SURGERY FOR PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA ECOG-ACRIN EA8141试验中AMVC组的长期随访结果：一项针对高危上尿路尿路上皮癌患者的新辅助全身化疗后行根治性手术的二期前瞻性临床试验

Journal of Urology

IF6.8

2026-05-01

PREAI

Zahalka, Ali; Chen, Yu-Hui; Margulis, Vitaly; Hoffman-Censits, Jean H.; Trabulsi, Edouard J.; Plimack, Elizabeth R.; Kessler, Elizabeth J.; Matin, Surena F.; Godoy, Guilherme; Alva, Ajjai; Hahn, Noah M.; Carducci, Michael A.

Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-01

PREAI

Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David

Exploring Health-Related quality of life across the disease spectrum in renal cell carcinoma: a conceptual domain analysis 探索肾细胞癌疾病谱中健康相关生命质量的领域分析

ONCOLOGIST

IF4.2

2025-10-01

OAAI

Shah, Koral; Bergerot, Paulo Gustavo; Castro, Daniela; Mercier, Benjamin; Nally, Elizabeth; Ali, Adil; Hutson, Thomas E.; Bex, Axel; Psutka, Sarah P.; Rini, Brian; Plimack, Elizabeth; Master, Viraj A.; Grunwald, Viktor; Albiges, Laurence; Choueri, Toni; Pal, Sumanta; Cella, David; Powles, Thomas; Bergerot, Cristiane Decat

Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma 三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应

ONCOLOGIST

IF4.2

2025-10-01

OAAI

Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David

Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank 开发生物标志物和风险分层方法：国际肾癌研讨会北美2024年思辨研讨会的共识声明

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

IF2.3

2025-09-01

PREAI

Shapiro, Daniel D.; Abel, Edwin Jason; Albiges, Laurence; Battle, Dena; Berg, Stephanie A.; Campbell, Matthew T.; Cella, David; Coleman, Katie; Garmezy, Benjamin; Geynisman, Daniel M.; Hall, Tasha; Henske, Elizabeth P.; Jonasch, Eric; Karam, Jose A.; La Rosa, Salvatore; Leibovich, Bradley C.; Maranchie, Jodi K.; Master, Viraj A.; Maughan, Benjamin L.; Mcgregor, Bradley A.; Msaouel, Pavlos; Pal, Sumanta K.; Perez, Jose; Plimack, Elizabeth R.; Psutka, Sarah P.; Riaz, Irbaz B.; Rini, Brian I.; Shuch, Brian; Simon, Marie Celeste; Singer, Eric A.; Smith, Andrew; Staehler, Michael; Tang, Chad; Tannir, Nizar M.; Vaishampayan, Ulka; Voss, Martin H.; Zakharia, Yousef; Zhang, Qing; Zhang, Tian; Carlo, Maria I.

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial 转移性激素敏感性前列腺癌患者按PSA nadir划分的十年生存率：ECOG-ACRIN 3805（CHAARTED）试验的长期生存分析

Annals of Oncology

IF65.4

2025-08-23

PREAI

A. Tripathi; Y. Chen; D.F. Jarrard; J.A. Garcia; R. Dreicer; G. Liu; M.H. Hussain; D.H. Shevrin; M.M. Cooney; M.A. Eisenberger; M. Kohli; E.R. Plimack; N.J. Vogelzang; J. Picus; M.A. Carducci; R.S. DiPaola; C.J. Sweeney

Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma 为转移性或局限性肾细胞癌患者开发健康相关生活质量问卷

European Urology Oncology

IF9.3

2025-08-19

PREAI

Cristiane D. Bergerot; David Cella; Paulo G. Bergerot; Daniela V. Castro; Benjamin D. Mercier; Elizabeth Nally; Adil A. Ali; Errol J. Philip; Thomas Hutson; Axel Bex; Sarah P. Psutka; Brian Rini; Elizabeth R. Plimack; Viktor Grünwald; Viraj Master; Laurence Albiges; Toni K. Choueiri; Sumanta K. Pal; Thomas Powles

Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial 帕博利珠单抗联合阿昔替尼对比舒尼替尼治疗晚期透明细胞肾细胞癌：KEYNOTE-426 III期试验的5年生存率和生物标志物分析

Nature Medicine

IF50

2025-08-01

OAAI

Brian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial 前列腺癌生命质量的遗传驱动因素：对E3805 CHAARTED试验中遗传多态性和患者报告结局的评估

European Urology Oncology

IF9.3

2025-04-16

PREAI

Daniel Sentana-Lledo; Xiangying Chu; Charles J. Ryan; Arjun Gupta; Christopher J. Sweeney; David F. Jarrard; Elizabeth R. Plimack; Benjamin A. Gartrell; Michael A. Carducci; Maha Hussain; Jorge A. Garcia; David Cella; Robert S. DiPaola; Mark Pomerantz; Alicia K. Morgans

Nivolumab plus ipilimumab versus sunitinib for fi rst-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial Nivolumab联合ipilimumab与舒尼替尼用于晚期肾细胞癌的一线治疗: CheckMate 214 III期试验的疗效和安全性的8年随访结果

ANNALS OF ONCOLOGY

IF65.4

2024-11-01

OAAI

Tannir, N. M.; Albiges, L.; Mcdermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthelemy, P.; Plimack, E. R.; Portat, C.; George, S.; Donskov, F.; Atkins, M. B.; Gurney, H.; Kollmannsberger, C. K.; Grimm, M. -o.; Barrios, C.; Tomita, Y.; Castellano, D.; Gruenwald, V.; Rini, B. I.; Jiang, R.; Desilva, H.; Fedorov, V.; Lee, C. -w.; Motzer, R. J.

Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial

EUROPEAN UROLOGY

IF25.2

2024-10-01

PREAI

Plimack, Elizabeth R.; Tangen, Catherine; Plets, Melissa; Kokate, Rutika; Xiu, Joanne; Nabhan, Chadi; Ross, Eric A.; Grundy, Erin; Choi, Woonyoung; Dinney, Colin P. N.; Lee, I. -Ling C.; Fong, Megan; Lucia, M. Scott; Daneshmand, Siamak; Theodorescu, Dan; Goldkorn, Amir; Lerner, Seth P.; Flaig, Thomas W.; McConkey, David J.

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study Epacadostat联合pembrolizumab与安慰剂联合pembrolizumab治疗晚期尿路上皮癌: 随机III期ECHO-303/KEYNOTE-698研究的结果

BMC CANCER

IF3.4

2024-07-25

OAAI

Cicin, Irfan; Plimack, Elizabeth R.; Gurney, Howard; Leibowitz, Raya; Alekseev, Boris Y.; Parnis, Francis X.; Peer, Avivit; Necchi, Andrea; Bellmunt, Joaquim; Nishiyama, Hiroyuki; Clark, Jason; Munteanu, Mihaela; Kataria, Ritesh; Jia, Calvin; Powles, Thomas; Sternberg, Cora N.

Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma 肺免疫预后指数 (LIPI) 作为转移性肾细胞癌预后生物标志物的验证

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-06-01

PREAI

Carril-Ajuria, Lucia; Lavaud, Pernelle; Dalban, Cecile; Negrier, Sylvie; Gravis, Gwenaelle; Motzer, Robert J.; Chevreau, Christine; Tannir, Nizar M.; Oudard, Stephane; McDermott, David F.; Laguerre, Brigitte; Hammers, Hans J.; Barthelemy, Philippe; Plimack, Elizabeth R.; Borchiellini, Delphine; Gross-Goupil, Marine; Jiang, Ruiyun; Lee, Chung-Wei; de Silva, Heshani; Rini, Brian I.; Escudier, Bernard; Albiges, Laurence

SLAMF7+CD8+T cells exhibit decreased anti-tumor responses in renal cell carcinoma

JOURNAL OF IMMUNOLOGY

IF3.4

2024-05-01

PREAI

Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael; Hammers, Hans; Signoretti, Sabina; Atkins, Michael; Wu, Catherine; Braun, David

Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-05-01

OAAI

Flaig, Thomas W.; Spiess, Philippe E.; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Buyyounouski, Mark K.; Chan, Kevin; Chang, Sam S.; Chang, Paul; Friedlander, Terence; Greenberg, Richard E.; Guru, Khurshid A.; Herr, Harry W.; Hoffman-Censits, Jean; Kaimakliotis, Hristos; Kishan, Amar U.; Kundu, Shilajit; Lele, Subodh M.; Mamtani, Ronac; Mian, Omar Y.; Michalski, Jeff; Montgomery, Jeffrey S.; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; Plimack, Elizabeth R.; Preston, Mark A.; Richards, Kyle; Sexton, Wade J.; Siefker-Radtke, Arlene O.; Stewart, Tyler; Sundi, Debasish; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L.; Cassara, Carly J.; Gurski, Lisa A.

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)nivolumab和savage nivolumab/ipilimumab治疗晚期透明细胞肾细胞癌的II期研究的无治疗生存结果 (HCRN GU16-260-Cohort A)

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-04-11

OAAI

Atkins, Michael B.; Jegede, Opeyemi A.; Haas, Naomi B.; Mcdermott, David F.; Bilen, Mehmet A.; Stein, Mark; Sosman, Jeffrey; Alter, Robert; Plimack, Elizabeth R.; Ornstein, Moshe C.; Hurwitz, Michael; Peace, David J.; Einstein, David; Catalano, Paul J.; Hammers, Hans; Regan, Meredith M.

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort Beztifan治疗晚期实体瘤的I期LITESPARK-001研究: 在透明细胞肾细胞癌队列中延长41个月的随访

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-01-01

PREAI

Jonasch, Eric; Bauer, Todd M.; Papadopoulos, Kyriakos P.; Plimack, Elizabeth R.; Merchan, Jaime R.; Mcdermott, David F.; Michaelson, M. Dror; Appleman, Leonard J.; Roy, Ananya; Perini, Rodolfo F.; Liu, Yanfang; Choueiri, Toni K.

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study[Eur Urol 84(5) (2023) 449-454]

EUROPEAN UROLOGY

IF25.2

2023-12-01

OAAI

Plimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Molife, L. Rhoda; Li, Chenxiang; Perini, Rodolfo; Bedke, Jens; Rini, Brian I.

研究方向